Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-12-20

Clinical Trial Update: Electroconvulsive Therapy for Treatment Refractory Schizophrenia - A Randomized, Double-blinded, Sham-controlled Study [NA]

View source ↗

Summary

A randomized, double-blind, sham-controlled trial evaluating electroconvulsive therapy for treatment-refractory schizophrenia was terminated before completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Electroconvulsive therapy

Snippet

Sponsor: University of Aarhus | Conditions: Treatment-refractory Schizophrenia | NA | Status: TERMINATED